| PERIOD ENDING | 1-Oct-09 | 2-Jul-09 | 2-Apr-09 | 1-Jan-09 | | Total Revenue | 673,500 | 789,200 | 665,600 | 711,700 | | Cost of Revenue | (110,000) | 428,000 | 532,500 | 746,000 | | | Gross Profit | 783,500 | 361,200 | 133,100 | (34,300) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 686,700 | 203,900 | 15,300 | (167,200) | | Non Recurring |
-
| 10,500 | 5,400 | 6,000 | | Others | 51,200 | 50,500 | 49,900 | 55,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 38,400 | 96,300 | 62,500 | 71,900 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (50,900) | 8,000 | 10,400 | 14,900 | | Earnings Before Interest And Taxes | (77,100) | 104,300 | 72,900 | 85,500 | | Interest Expense | (74,200) | 37,000 | 37,200 | 35,600 | | Income Before Tax | (2,900) | 67,300 | 35,700 | 49,900 | | Income Tax Expense | (1,000) | 26,900 | 14,400 | 19,800 | | Minority Interest |
-
|
-
|
-
| (800) | | | | Net Income From Continuing Ops | 17,700 | 40,400 | 21,300 | 30,100 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,700) | 40,400 | 21,300 | 30,100 | | Preferred Stock And Other Adjustments | (100) | 100 |
-
|
-
| | | Net Income Applicable To Common Shares | ($1,800) | $40,500 | $21,300 | $30,100 |
|
0.51% Nasdaq 
Income Statement
